Upcoming conference attendance

Summary by AI BETAClose X

Arecor Therapeutics plc announced its attendance at two major industry conferences: the American Diabetes Association (ADA) Scientific Sessions from June 5-8, 2026, in New Orleans, and the BIO International Convention from June 22-25, 2026, in San Diego. The company will showcase its lead clinical-stage product, AT278, an ultra-concentrated, ultra-rapid acting insulin designed for advanced automated insulin delivery systems. These events provide opportunities for Arecor's leadership and business development team to engage with key opinion leaders, researchers, investors, and potential partners, aiming to advance its pipeline and collaborations.

Disclaimer*

UK 100

Latest directors dealings